Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma

DOI: 10.2298/vsp0803229m

Keywords: lymphoma , non-Hodgkin , antibodies , monoclonal , drug therapy , drug therapy , combination , antineoplastic combined chemotherapy protocols

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text